查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1957312

勃起功能障礙治療設備市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、原因、最終用戶、地區和競爭格局分類，2021-2031年

Erectile Dysfunction Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Cause, By End-user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球治療勃起功能障礙設備的市場預計將從 2025 年的 15.2 億美元成長到 2031 年的 23.9 億美元，複合年成長率為 7.83%。

該市場涵蓋真空勃起裝置、陰莖人工替代物和衝擊波治療設備，旨在治療勃起功能障礙。推動這一市場成長的關鍵因素包括糖尿病和心血管疾病盛行率的上升（需要生理干預）以及老齡化人口對持久性機械解決方案的需求。美國泌尿系統協會2024年的報告指出，“86%的受訪泌尿系統經常使用涉及真空泵等裝置的陰莖康復療法來幫助患者康復”，這凸顯了這些裝置在治療複雜泌尿系統疾病中發揮的關鍵臨床作用。

市場概覽
預測期 2027-2031
市場規模：2025年 15.2億美元
市場規模：2031年 23.9億美元
複合年成長率：2026-2031年 7.83%
成長最快的細分市場 陰莖植入
最大的市場 北美洲

儘管存在這些成長要素，但手術植入的高成本和侵入性仍構成市場發展的重大障礙。陰莖假人工替代物手術有感染疾病和機械故障等醫療風險，常令潛在患者望而卻步。此外，許多地區對這些昂貴醫療設備的保險覆蓋範圍有限，限制了其價格親民的普及，阻礙了市場更廣泛的接受度。

市場促進因素

文明病（尤其是心血管疾病和糖尿病）的日益流行，是全球勃起功能障礙治療器材市場的主要驅動力。隨著這些系統性疾病的進展，它們會導致嚴重的神經血管損傷，使口服藥物失效，從而需要陰莖人工替代物和真空勃起裝置等機械干預措施。代謝性疾病與性功能障礙之間的這種關聯顯著擴大了潛在患者群體。例如，2024年10月發表在《報導醫學》（News-Medical）上的一篇題為“新研究發現三分之二的糖尿病男性患有勃起功能障礙”的文章報道稱，全球糖尿病患者中勃起功能障礙的患病率約為65.8%，這保證了對非藥物治療方案的穩定需求。

同時，撓性可充氣陰莖植入的技術創新正在提升器械的耐用性和患者滿意度，從而加速市場成長。製造商正致力於研發先進、抗感染且易於使用的假體，以滿足尋求長期治療方案而非臨時性解決方案的男性的需求。這項需求在主要產業參與者的財務表現中得到了清晰的體現；根據波士頓科學公司2024會計年度第三季財務及業務亮點報告，該公司泌尿系統領域的全球銷售額成長了10.3%，主要得益於其假體和前列腺相關產品組合的成長。同樣，科樂普公司報告稱，其2024會計年度介入泌尿系統業務實現了5%的內部成長，證實了這些治療器械的持續臨床應用和投資。

市場挑戰

手術植入，尤其是陰莖人工替代物，其高成本和侵入性是全球勃起功能障礙治療器械市場的主要障礙。這些複雜的手術存在重大的醫療風險，包括機械故障和感染，導致相當一部分合格的患者在接受手術前猶豫不決。因此，對侵入性手術的抵抗情緒限制了這些長期治療方法的潛在市場，迫使患者在明明有長期治療選擇的情況下，仍然依賴暫時性或效果較差的替代方案。

臨床數據顯示術後功能障礙和患者不滿意，這進一步加劇了患者的猶豫。根據2024年北美性學學會的報告，「接受陰莖人工替代物的患者中，36.7%在術後12個月報告難以達到性高潮，31.6%的患者出現人工替代物減壓問題。」這些關於術後功能和機械可靠性的統計數據，加深了患者對這些昂貴醫療設備相關風險的擔憂。潛在的功能障礙與患者滿意度下降之間的直接聯繫，顯著限制了植入式醫療設備領域收入的成長。

市場趨勢

低強度體外震波療法 (Li-ESWT) 的快速普及正在改變市場格局，將臨床重點從症狀治療轉向修復性治療。與繞過生理缺陷的機械幫浦和植入不同，Li-ESWT 可促進新生血管生成並修復潛在的勃起組織，為尋求非侵入性和持久改善的患者提供了一種極具吸引力的選擇。這一轉變得到了新的長期數據的支持。根據 Storz Medical 於 2025 年 2 月發表的報導《低強度衝擊波療法能否成為勃起功能障礙的持久治療方案？ 》，一項隨機對照試驗表明，接受 Li-ESWT 治療的患者在男性性功能評估量表 (SHIM) 評分方面獲得了持續改善，12 個月時評分從基準10.8 分提高到 15.6 分。

同時，親水性和抗感染植入塗層技術的進步正在降低與陰莖人工替代物相關的關鍵醫療風險，並擴大潛在患者群體。製造商正在推出新的表面改質技術，以改善潤滑並促進抗生素吸收，從而減輕先前令患者和外科醫生望而卻步的感染擔憂。這些改進帶來了切實的安全提升。根據美國國立衛生研究院 (NIH) 於 2025 年 1 月發表的論文《新型 Rigicon Infla10 充氣式陰莖人工替代物的患者滿意度研究》，在臨床評估中，塗層 Infla10 裝置在 19 個月的中位追蹤期內，感染相關切除率僅為 1.7%，這提高了下一代植入的商業性吸引力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球勃起功能障礙治療器材市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（真空收縮裝置、陰莖植入、衝擊波療法等）
    • 病因（血管疾病、糖尿病、神經病變等）
    • 依最終使用者（醫院/診所、門診手術中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美治療勃起功能障礙器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲勃起功能障礙治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區勃起功能障礙治療器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲勃起功能障礙治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲勃起功能障礙治療設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球勃起功能障礙治療設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Boston Scientific Corporation
  • Coloplast Corp.
  • Zephyr Surgical Implants
  • Owen Mumford Ltd.
  • Augusta Medical Systems
  • Storz medical AG,
  • The Elator AB
  • Timm Medical Technologies Ltd.
  • Alma Lasers Ltd
  • Futura Medical plc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19561

The Global Erectile Dysfunction Treatment Devices Market is projected to expand from USD 1.52 Billion in 2025 to USD 2.39 Billion by 2031, reflecting a CAGR of 7.83%. This market encompasses vacuum erection systems, penile prostheses, and shock wave therapy equipment aimed at managing impotence. The primary catalysts for this growth are the increasing prevalence of diabetes and cardiovascular diseases, which often require physiological interventions, alongside an aging demographic seeking durable mechanical solutions. A 2024 report by the 'American Urological Association' highlighted that '86% of surveyed urologists utilized penile rehabilitation therapies that frequently employ devices such as vacuum pumps for patient recovery', underscoring the critical clinical role these apparatuses play in treating complex urological conditions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.52 Billion
Market Size 2031USD 2.39 Billion
CAGR 2026-20317.83%
Fastest Growing SegmentPenile Implants
Largest MarketNorth America

Despite these growth factors, the market faces substantial obstacles due to the high costs and invasive nature of surgical implants. Procedures involving penile prostheses carry medical risks, such as infection and mechanical malfunction, which frequently discourage potential candidates. Additionally, limited insurance coverage for these premium devices in many regions restricts their affordability, thereby hampering broader accessibility within the market.

Market Driver

The rising prevalence of lifestyle-related chronic conditions, particularly cardiovascular diseases and diabetes, serves as a major driver for the Global Erectile Dysfunction Treatment Devices Market. As these systemic pathologies advance, they often result in severe neural and vascular damage that renders oral pharmacotherapies ineffective, necessitating mechanical interventions like penile prostheses or vacuum erection systems. This link between metabolic disorders and sexual dysfunction vastly increases the potential patient base. For instance, an article in News-Medical from October 2024, titled 'New study reveals two-thirds of diabetic men suffer from erectile dysfunction', noted that the global prevalence of erectile dysfunction among diabetic patients is approximately 65.8%, ensuring steady demand for non-pharmacological management options.

Concurrently, technological innovations in malleable and inflatable penile implants have accelerated market growth by improving device durability and patient satisfaction. Manufacturers are focusing on advanced, infection-resistant, and user-friendly prosthetics that attract men seeking long-term curative solutions rather than temporary fixes. This demand is evident in the financial results of key industry players; according to Boston Scientific's 'Q3 2024 Financial and Operational Highlights', the company saw a 10.3% reported rise in global Urology sales, largely attributed to their prosthetic and prostate portfolios. Similarly, Coloplast reported that their Interventional Urology business achieved an organic growth rate of 5% in the 2024 financial year, confirming the sustained clinical utilization and investment in these therapeutic devices.

Market Challenge

The high cost and invasive nature of surgical implants, specifically penile prostheses, constitute a major hurdle for the Global Erectile Dysfunction Treatment Devices Market. These complex procedures involve significant medical risks, including mechanical failure and infection, which deter a substantial portion of the eligible patient population. Consequently, the hesitation to undergo invasive surgery limits the addressable market for these durable solutions, often compelling patients to depend on temporary or less effective alternatives despite the existence of long-term options.

This reluctance is reinforced by clinical data pointing to functional difficulties and dissatisfaction following surgery. According to the 'Sexual Medicine Society of North America' in '2024', '36.7% of patients receiving penile prosthesis implants reported difficulties reaching orgasm and 31.6% experienced issues with prosthesis deflation at the 12-month mark'. These statistics regarding post-operative functionality and mechanical reliability validate patient apprehensions about the risks associated with these premium devices. This direct link between potential malfunction and patient dissatisfaction significantly restricts adoption rates, thereby limiting revenue growth within the implantable device segment.

Market Trends

The accelerating adoption of Low-Intensity Extracorporeal Shock Wave Therapy (Li-ESWT) is transforming the market by shifting the clinical focus from symptomatic management to restorative cures. Unlike mechanical pumps or implants that bypass physiological deficits, Li-ESWT fosters neovascularization to rehabilitate underlying erectile tissue, offering a compelling option for patients desiring non-invasive, durable improvements. This shift is supported by emerging long-term data; according to a Storz Medical article from February 2025 titled 'Is low-intensity shockwave therapy for erectile dysfunction a durable treatment option?', a randomized controlled trial showed that patients receiving Li-ESWT achieved sustained increases in Sexual Health Inventory for Men (SHIM) scores, improving from a baseline of 10.8 to 15.6 at the 12-month assessment.

Simultaneously, advancements in hydrophilic and infection-resistant implant coatings are addressing major medical risks associated with penile prostheses, thereby widening the potential patient pool. Manufacturers are incorporating novel surface modifications that improve lubricity and aid antibiotic absorption, mitigating infection concerns that have historically deterred patients and surgeons. These improvements are demonstrating tangible safety benefits; according to the National Institutes of Health in a January 2025 article titled 'Patient satisfaction study for the new Rigicon Infla10 inflatable penile prosthesis', a clinical evaluation found an exceptionally low infection-related explant rate of only 1.7% over a median follow-up of 19 months for the coated Infla10 device, enhancing the commercial appeal of next-generation implants.

Key Market Players

  • Boston Scientific Corporation
  • Coloplast Corp.
  • Zephyr Surgical Implants
  • Owen Mumford Ltd.
  • Augusta Medical Systems
  • Storz medical AG,
  • The Elator AB
  • Timm Medical Technologies Ltd.
  • Alma Lasers Ltd
  • Futura Medical plc

Report Scope

In this report, the Global Erectile Dysfunction Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Erectile Dysfunction Treatment Devices Market, By Type

  • Vacuum Constriction Devices
  • Penile Implants
  • Shockwave Therapy
  • Others

Erectile Dysfunction Treatment Devices Market, By Cause

  • Vascular Disorders and Diabetes
  • Neurologic disorder
  • Others

Erectile Dysfunction Treatment Devices Market, By End-user

  • Hospital & Clinics
  • Ambulatory Surgery Center
  • Others

Erectile Dysfunction Treatment Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Erectile Dysfunction Treatment Devices Market.

Available Customizations:

Global Erectile Dysfunction Treatment Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Erectile Dysfunction Treatment Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Vacuum Constriction Devices, Penile Implants, Shockwave Therapy, Others)
    • 5.2.2. By Cause (Vascular Disorders and Diabetes, Neurologic disorder, Others)
    • 5.2.3. By End-user (Hospital & Clinics, Ambulatory Surgery Center, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Erectile Dysfunction Treatment Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Cause
    • 6.2.3. By End-user
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Erectile Dysfunction Treatment Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Cause
        • 6.3.1.2.3. By End-user
    • 6.3.2. Canada Erectile Dysfunction Treatment Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Cause
        • 6.3.2.2.3. By End-user
    • 6.3.3. Mexico Erectile Dysfunction Treatment Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Cause
        • 6.3.3.2.3. By End-user

7. Europe Erectile Dysfunction Treatment Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Cause
    • 7.2.3. By End-user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Erectile Dysfunction Treatment Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Cause
        • 7.3.1.2.3. By End-user
    • 7.3.2. France Erectile Dysfunction Treatment Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Cause
        • 7.3.2.2.3. By End-user
    • 7.3.3. United Kingdom Erectile Dysfunction Treatment Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Cause
        • 7.3.3.2.3. By End-user
    • 7.3.4. Italy Erectile Dysfunction Treatment Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Cause
        • 7.3.4.2.3. By End-user
    • 7.3.5. Spain Erectile Dysfunction Treatment Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Cause
        • 7.3.5.2.3. By End-user

8. Asia Pacific Erectile Dysfunction Treatment Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Cause
    • 8.2.3. By End-user
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Erectile Dysfunction Treatment Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Cause
        • 8.3.1.2.3. By End-user
    • 8.3.2. India Erectile Dysfunction Treatment Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Cause
        • 8.3.2.2.3. By End-user
    • 8.3.3. Japan Erectile Dysfunction Treatment Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Cause
        • 8.3.3.2.3. By End-user
    • 8.3.4. South Korea Erectile Dysfunction Treatment Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Cause
        • 8.3.4.2.3. By End-user
    • 8.3.5. Australia Erectile Dysfunction Treatment Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Cause
        • 8.3.5.2.3. By End-user

9. Middle East & Africa Erectile Dysfunction Treatment Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Cause
    • 9.2.3. By End-user
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Erectile Dysfunction Treatment Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Cause
        • 9.3.1.2.3. By End-user
    • 9.3.2. UAE Erectile Dysfunction Treatment Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Cause
        • 9.3.2.2.3. By End-user
    • 9.3.3. South Africa Erectile Dysfunction Treatment Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Cause
        • 9.3.3.2.3. By End-user

10. South America Erectile Dysfunction Treatment Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Cause
    • 10.2.3. By End-user
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Erectile Dysfunction Treatment Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Cause
        • 10.3.1.2.3. By End-user
    • 10.3.2. Colombia Erectile Dysfunction Treatment Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Cause
        • 10.3.2.2.3. By End-user
    • 10.3.3. Argentina Erectile Dysfunction Treatment Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Cause
        • 10.3.3.2.3. By End-user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Erectile Dysfunction Treatment Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boston Scientific Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Coloplast Corp.
  • 15.3. Zephyr Surgical Implants
  • 15.4. Owen Mumford Ltd.
  • 15.5. Augusta Medical Systems
  • 15.6. Storz medical AG,
  • 15.7. The Elator AB
  • 15.8. Timm Medical Technologies Ltd.
  • 15.9. Alma Lasers Ltd
  • 15.10. Futura Medical plc

16. Strategic Recommendations

17. About Us & Disclaimer